Public Health Surveillance for Infectious Diseases

Principles & Practice of Public Health Surveillance

Volumn , Issue , 2010, Pages

  Van Beneden, Chris A ^a   Lynfield, Ruth ^b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

Author keywords

Globalization; Infectious disease; One world one health; Public health; Surveillance

Indexed keywords

EID: 84920758325     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195372922.003.0011     Document Type: Chapter

References (48)

1. World Health Organization. The global burden of disease: 2004 update. 2008. . Accessed March 10, 2009.
2. King LJ. Collaboration in public health: a new global imperative. Public Health Rep 2008; 123:264-265.
3. M'ikanatha NM, Lynfield R, Julian KG, Van Beneden CA, de Valk H. Infectious disease surveillance: a cornerstone for prevention and control. In: M'ikanatha, Lynfield, Van Beneden, de Valk, eds. Infectious Disease Surveillance, 1st ed. Oxford, UK: Blackwell Publishing; 2007:3-17.
4. Russell CA, Jones TC, Barr IG, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008;26(Suppl 4):D31-D34.
5. Global influenza surveillance. A World Health Organization (WHO) website. . Accessed March 11, 2009.
6. Falzon D, Belghiti F. Tuberculosis: still a concern for all countries in Europe. Euro Surveill 2007;12(12) pii-3159. . Accessed March 4, 2009.
7. Guris D, Harpaz R, Redd SB, Smith NJ, Papania MH. Measles surveillance in the United States: an overview. J Infect Dis 2004;189(Suppl. 1):S177-S184.
8. DeVries A, Lees C, Rainbow J, Lynfield R. Explaining the unexplained: identifying causes of critical illness and death in Minnesota. Minn Med 2008; 91:34-36.
9. Como-Sabetti K, Harriman KH, Buck JM, Glennen A, Boxrud DJ, Lynfield R. Community-associated methicillin-resistant Staphylococcus aureus: trends in case and isolate characteristics from six years of prospective surveillance. Public Health Rep 2009;124(3):427-435.
10. Wilder-Smith A, Goh KT, Paton NI. Experience of severe acute respiratory syndrome in Singapore: importance of cases, and defense strategies at the airport. J Travel Med 2003; 10:259-262.
11. Vaccine Adverse Event Reporting System (VAERS). A Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) website. . Accessed March 11, 2009.
12. Gonococcal Isolate Surveillance Project (GISP). Centers for Disease Control and Prevention website. . Updated June 4, 2008. Accessed March 11, 2009.
13. Flu activity and surveillance. Centers for Disease Control and Prevention website. . Updated March 6, 2009. Accessed March 11, 2009.
14. National Healthcare Safety Network (NHSN) Centers for Disease Control and Prevention website. . Updated May 22, 2008. Accessed March 4, 2009.
15. Active Bacterial Core Surveillance system (ABCs) of the Centers for Disease Control and Prevention website. . Updated February 24, 2009. Accessed March 11, 2009.
16. Hammerum AM, Heuer OE, Emborg HD, et al. Danish integrated antimicrobial resistance monitoring and research program. Emerg Infect Dis 2007; 13:1632-1639.
17. Gilbert JM, White DG, McDermott PF. The US national antimicrobial resistance monitoring system. Future Microbiol 2007; 2:493-500.
18. Swaminathan B, Gerner-Smidt P, Ng LK, et al. Building PulseNet International: an interconnected system of laboratory networks to facilitate timely public health recognition and response to foodborne disease outbreaks and emerging foodborne diseases. Foodborne Pathog Dis 2006; 3:36-50.
19. Centers for Disease Control and Prevention. Progress in Improving State and Local Disease Surveillance-United States, 2000-2005. MMWR 2005; 54 (33):822-825.
20. M'ikanatha NM, Rohn DD, Welliver DP, McAdams T, Julian KG. Use of the World Wide Web to enhance infectious disease surveillance. In: M'ikanatha, Lynfield, Van Beneden, de Valk, eds. Infectious Disease Surveillance, 1st ed. Oxford, UK: Blackwell Publishing; 2007:281-293.
21. Vanden Eng JL, Wolkon A, Frolov AS. Use of handheld computers with global positioning systems for probability sampling and data entry in household surveys. Am J Trop Med Hyg, 2007;77(2):393-399.
22. Farley J, Srinivasan A, Richards A, Song X, McEachen J, Perl T. Handheld computer surveillance: Shoe-leather epidemiology in the "palm" of your hand. Am J Infect Control 2005;33(8):444-449.
23. National Healthcare Safety Network (NHSN). A Centers for Disease Control and Prevention (CDC) website. . Updated May 22, 2008. Accessed March 30, 2009.
24. Glynn MK, Lee LM, McKenna MT. The status of national HIV Case Surveillance, United States 2006. Public Health Rep 2007;122(Suppl 1):63-71.
25. Schrag SJ, Brooks JT, Van Beneden C, et al. SARS surveillance in the United States during the emergency public health response, March-July, 2003. Emerg Infect Dis 2004;10(2):185-194.
26. Centers for Disease Control and Prevention. Framework for evaluating public health surveillance systems for early detection of outbreaks MMWR 2004; 53(RR5):1-11.
27. Hogan WR, Tsui FC, Ivanov O, et al. Detection of pediatric respiratory and diarrheal outbreaks from sales of over-the-counter electrolyte products. J Am Med Inform Assoc 2003; 10:555-562.
28. Public Health Laboratory Information System (PHLIS). A Centers for Disease Control and Prevention website. . Updated December 1, 2005. Accessed March 30, 2009.
29. Rassler S, Rubin DB, Zell ER. Incomplete data in epidemiology and medical statistics. In: Rao CR, Miller JP, Rao DC, eds. Handbook of Statistics, Vol 27. Elsevier BV. 2008:569-601.
30. Rogers DJ, Randolph SE. Studying the global distribution of infectious diseases using GIS and RS. Nat Rev Microbiol 2003;1:231-237. .
31. Seto E, Moore CG, Hoskins RE. Use of geographic information systems and remote sensing for infectious disease surveillance. In: M'ikanatha, Lynfield, Van Beneden, de Valk, eds. Infectious Disease Surveillance, 1st ed. Oxford, UK: Blackwell Publishing; 2007: 408-418.
32. SAS website. . Accessed March 30, 2009.
33. SPSS website. . Accessed March 30, 2009.
34. Stata website. . Accessed March 30, 2009.
35. Holmes JH, Rohn DD, Hilbe JM. Software applications for analysis of surveillance data. In: M'ikanatha, Lynfield, Van Beneden, de Valk, eds. Infectious Disease Surveillance. 1st ed. Oxford, UK: Blackwell Publishing; 2007:363-366.
36. International Health Regulations. World Health Organization website, 2005 . Accessed March 11, 2009.
37. Centers for Disease Control and Prevention. Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections. MMWR 2007;56(14):332-336.
38. Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early onset group B streptococcal disease in neonates. N Engl J Med 2002; 347:233-239.
39. Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease. MMWR 2002;51(RR11):1-22.
40. Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2005. MMWR 2008;57(6):144-148.
41. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. New Engl J Med 2001; 344:564-572.
42. Centers for Disease Control and Prevention. Emergence of fluoroquinolone-resistant Neisseria meningitidis-Minnesota and North Dakota, 2007-2008. MMWR 2008; 57:173-175.
43. Legislation for public health emergencies. Centers for Disease Control and Prevention website. . Accessed March 11, 2009.
44. Impacts of antimicrobial growth promoter termination in Denmark. World Health Organization (WHO) website. Posted 2003 (WHO reference:WHO/CDS/CPE/ZFK/2003.1). Accessed March 11, 2009.
45. Hall HI, Song R, Gerstle JE, Lee LM. Assessing the completeness of reporting of Human Immunodeficiency Virus diagnoses in 2002-2003: capture-recapture methods. Am J Epidemiol 2006;164(4):391-397.
46. Schrag SJ, Zell E, Schuchat A, Whitney CG. Evaluation of sentinel surveillance for drug-resistant Streptococcus pneumoniae. Emerg Inf Dis 2002;8(5):496-502.
47. Van Beneden CA, Lexau C, Baughman W, et al. Use of aggregated antibiogram data as a method for monitoring drug-resistant Streptococcus pneumoniae in the community. Emerg Infect Dis 2003;9(9):1089-1095.
48. Hall HI, Mokotoff ED. Setting standards and an evaluation framework for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome surveillance. J Public Health Manag Pract 2007;13(5):519-523.